Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

ClinicalTrials.gov ID: NCT02798471

Public ClinicalTrials.gov record NCT02798471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an event driven Phase 3, prospective, randomized, open-label, blinded endpoint evaluation (PROBE) parallel group study in subjects with confirmed VTE. This study is designed to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban and to compare the efficacy and safety of edoxaban against standard of care in pediatric subjects with confirmed VTE.

Study identification

NCT ID
NCT02798471
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
290 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Day to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2017 (Actual)
Primary completion
May 24, 2022 (Actual)
Completion
May 24, 2022 (Actual)
Last update posted
Feb 28, 2025

2017 – 2022

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Banner University Medical Center Tucson Arizona 85724 —
Children's Hospital Los Angeles Los Angeles California 90027 —
UCLA Medical Center CAR Los Angeles California 90095 —
Stanford University Medical Center Stanford California 94305 —
University of Miami Miller School of Medicine Miami Florida 33136 —
University of South Florida Tampa Florida 33606 —
Rush University Medical Center Chicago Illinois 60612 —
Advocate Children's Hospital-Oak Lawn Oak Lawn Illinois 60453 —
Indiana Hemophilia and Thrombosis Center Indianapolis Indiana 46260 —
University of Louisville Louisville Kentucky 40202 —
Spectrum Health Helen DeVos Children's Hospital Grand Rapids Grand Rapids Michigan 49503 —
Children's Hospital & Clinics of Minnesota Minneapolis Minnesota 55404 —
Washington University School of Medicine St Louis Missouri 63110 —
University North Carolina- Chapel Hill Chapel Hill North Carolina 27517 —
Levine Children's Hospital Charlotte Charlotte North Carolina 28204 —
The Presbyterian Hospital Charlotte North Carolina 28210 —
East Carolina University Greenville North Carolina 27858 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Hasbro Children's Hospital Providence Rhode Island 02903 —
Le Bonheur Childrens Hospital Memphis Tennessee 38105 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 118 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02798471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2025 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02798471 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →